Personalized Real-time Adaptive Cavitation-Enhanced Ultrasound Treatment Planning

A next-generation system for cavitation-enhanced ultrasound treatment planning that integrates real-time monitoring, AI-driven optimization, and personalized treatment protocols to revolutionize drug delivery and treatment outcomes.

The original patent disclosed a simulation-based drug treatment planning system, but it had limitations in terms of real-time adaptability and personalized treatment. The new inventive concept addresses these limitations by introducing a wearable implantable device, neural network-based AI module, and digital twin modeling to enable real-time adaptive drug delivery and closed-loop control.

The inventive concept comprises a wearable implantable device that monitors a patient's physiological responses to a cavitation-enhanced ultrasound procedure and adjusts sonication parameters in real-time. The device is integrated with a neural network-based AI module that predicts optimal sonication parameters based on real-time data from the patient's physiological responses. Additionally, the system utilizes a digital twin model of the patient's anatomy and a machine learning-based optimization engine to predict optimal treatment protocols for individual patients. The system enables personalized, closed-loop control of the ultrasound procedure, ensuring optimal treatment outcomes and minimizing adverse effects.

The new inventive concept introduces the novel combination of real-time monitoring, AI-driven optimization, and digital twin modeling to enable personalized and adaptive cavitation-enhanced ultrasound treatment planning. This represents a significant departure from the original patent's simulation-based approach and provides a paradigm shift in the field of drug treatment planning.

Alternative embodiments of the inventive concept could include the use of different types of sensors, AI algorithms, or optimization engines. Variations could also include the integration of additional data sources, such as medical imaging or genomic data, to further personalize treatment protocols.

The inventive concept has significant commercial potential in the pharmaceutical and medical device industries, particularly in the areas of targeted drug delivery and personalized medicine. The system could be marketed as a platform for optimizing treatment outcomes and reducing adverse effects in a variety of therapeutic applications.